Mach-1 Financial Group’s Biogen BIIB Stock Holding History

Mach-1 Financial Group’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-60	Closed	-$16K	–	191
2022 Q3	$16K	Hold	60	–	–	0.02%	178
2022 Q2	$12K	Buy	+60	New	+$12.3K	0.01%	214

Other funds holding BIIB

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Mach-1 Financial Group's BIIB Position: Q4 2022 in Review

Mach-1 Financial Group sold out of Biogen (BIIB) in Q4 2022, closing a stake of 60 shares — an estimated $16K sold.

Mach-1 Financial Group first reported a position in BIIB in Q2 2022 and held it in 2 quarters. The position peaked at $16K in Q3 2022. 1,031 funds tracked by Wall St. Rank hold BIIB as of Q4 2022.

Mach-1 Financial Group reported no remaining Biogen position as of Q4 2022 after selling out during the quarter.
Mach-1 Financial Group sold 60 Biogen shares in Q4 2022, an estimated $16K.
Mach-1 Financial Group first reported a position in Biogen in Q2 2022 and held it in 2 quarters.
Mach-1 Financial Group's Biogen position peaked at $16K in Q3 2022.
1,031 funds tracked by Wall St. Rank held Biogen as of Q4 2022.

Based on Mach-1 Financial Group's 13F filing for Q4 2022, filed 2 Feb 2023.